BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Kidney
,
Laser capture microdissection
,
Rapamycin
,
rs6983267
,
DNMT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
WX-UK1
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synt…
Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications.
Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the…
Activation of the anti-cancer agent upamostat by the mARC enzyme system.
Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signal…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ